In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment

R J U Lories, I Derese, Cosimo De Bari, F P Luyten

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

BACKGROUND: Fibroblast-like synovial cells (FLS) can be cultured and expanded in vitro in monolayer. Little is known about the growth characteristics of FLS derived from different patients. OBJECTIVE: To study FLS cultures, with particular attention to differences in growth rate of FLS from patients with rheumatoid arthritis (RA) and from other arthritic patients. Additionally, to analyse the influence of methotrexate (MTX) treatment, patient age, and disease duration on FLS growth characteristics. MATERIALS AND METHODS: FLS were isolated from needle arthroscopy biopsy specimens. Twenty four patients (11 RA, 8 spondyloarthropathy, 1 osteoarthritis, and 4 undifferentiated arthritis) were studied. FLS population doubling time was determined between passage 2 and passage 5. Differences in population doubling time between RA and non-RA FLS and between FLS from patients receiving MTX and those not receiving this drug were analysed. In addition, possible correlations between FLS population doubling time and patient age or disease duration were examined. RESULTS: In vitro monolayer FLS cultures from needle arthroscopy biopsy specimens showed linear growth characteristics. Cell growth rate was not correlated with type of disease. Cells from patients undergoing treatment with MTX showed a longer population doubling time than FLS from patients not receiving this drug (Mann-Whitney test, p
Original languageEnglish
Pages (from-to)568-571
Number of pages4
JournalAnnals of the Rheumatic Diseases
Volume62
Issue number6
DOIs
Publication statusPublished - 1 Jun 2003

Fingerprint

Fibroblasts
Methotrexate
Growth
Therapeutics
Patient treatment
Arthritis
Rheumatoid Arthritis
Biopsy
Arthroscopy
Cell growth
Needle Biopsy
Cell culture
Needles
Population
In Vitro Techniques
Monolayers
Cell Culture Techniques
Spondylarthropathies
Osteoarthritis
Pharmaceutical Preparations

Keywords

  • Adult
  • Age Factors
  • Aged
  • Antirheumatic Agents
  • Arthritis
  • Arthritis, Rheumatoid
  • Biopsy, Needle
  • Cell Division
  • Cells, Cultured
  • Female
  • Fibroblasts
  • Humans
  • Male
  • Methotrexate
  • Middle Aged
  • Synovial Membrane
  • Time Factors

Cite this

In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment. / Lories, R J U; Derese, I; De Bari, Cosimo; Luyten, F P.

In: Annals of the Rheumatic Diseases, Vol. 62, No. 6, 01.06.2003, p. 568-571.

Research output: Contribution to journalArticle

@article{60efa998785747a593b326565fe04ed2,
title = "In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment",
abstract = "BACKGROUND: Fibroblast-like synovial cells (FLS) can be cultured and expanded in vitro in monolayer. Little is known about the growth characteristics of FLS derived from different patients. OBJECTIVE: To study FLS cultures, with particular attention to differences in growth rate of FLS from patients with rheumatoid arthritis (RA) and from other arthritic patients. Additionally, to analyse the influence of methotrexate (MTX) treatment, patient age, and disease duration on FLS growth characteristics. MATERIALS AND METHODS: FLS were isolated from needle arthroscopy biopsy specimens. Twenty four patients (11 RA, 8 spondyloarthropathy, 1 osteoarthritis, and 4 undifferentiated arthritis) were studied. FLS population doubling time was determined between passage 2 and passage 5. Differences in population doubling time between RA and non-RA FLS and between FLS from patients receiving MTX and those not receiving this drug were analysed. In addition, possible correlations between FLS population doubling time and patient age or disease duration were examined. RESULTS: In vitro monolayer FLS cultures from needle arthroscopy biopsy specimens showed linear growth characteristics. Cell growth rate was not correlated with type of disease. Cells from patients undergoing treatment with MTX showed a longer population doubling time than FLS from patients not receiving this drug (Mann-Whitney test, p",
keywords = "Adult, Age Factors, Aged, Antirheumatic Agents, Arthritis, Arthritis, Rheumatoid, Biopsy, Needle, Cell Division, Cells, Cultured, Female, Fibroblasts, Humans, Male, Methotrexate, Middle Aged, Synovial Membrane, Time Factors",
author = "Lories, {R J U} and I Derese and {De Bari}, Cosimo and Luyten, {F P}",
year = "2003",
month = "6",
day = "1",
doi = "10.1136/ard.62.6.568",
language = "English",
volume = "62",
pages = "568--571",
journal = "Annals of the Rheumatic Diseases",
issn = "0003-4967",
publisher = "BMJ Publishing Group",
number = "6",

}

TY - JOUR

T1 - In vitro growth rate of fibroblast-like synovial cells is reduced by methotrexate treatment

AU - Lories, R J U

AU - Derese, I

AU - De Bari, Cosimo

AU - Luyten, F P

PY - 2003/6/1

Y1 - 2003/6/1

N2 - BACKGROUND: Fibroblast-like synovial cells (FLS) can be cultured and expanded in vitro in monolayer. Little is known about the growth characteristics of FLS derived from different patients. OBJECTIVE: To study FLS cultures, with particular attention to differences in growth rate of FLS from patients with rheumatoid arthritis (RA) and from other arthritic patients. Additionally, to analyse the influence of methotrexate (MTX) treatment, patient age, and disease duration on FLS growth characteristics. MATERIALS AND METHODS: FLS were isolated from needle arthroscopy biopsy specimens. Twenty four patients (11 RA, 8 spondyloarthropathy, 1 osteoarthritis, and 4 undifferentiated arthritis) were studied. FLS population doubling time was determined between passage 2 and passage 5. Differences in population doubling time between RA and non-RA FLS and between FLS from patients receiving MTX and those not receiving this drug were analysed. In addition, possible correlations between FLS population doubling time and patient age or disease duration were examined. RESULTS: In vitro monolayer FLS cultures from needle arthroscopy biopsy specimens showed linear growth characteristics. Cell growth rate was not correlated with type of disease. Cells from patients undergoing treatment with MTX showed a longer population doubling time than FLS from patients not receiving this drug (Mann-Whitney test, p

AB - BACKGROUND: Fibroblast-like synovial cells (FLS) can be cultured and expanded in vitro in monolayer. Little is known about the growth characteristics of FLS derived from different patients. OBJECTIVE: To study FLS cultures, with particular attention to differences in growth rate of FLS from patients with rheumatoid arthritis (RA) and from other arthritic patients. Additionally, to analyse the influence of methotrexate (MTX) treatment, patient age, and disease duration on FLS growth characteristics. MATERIALS AND METHODS: FLS were isolated from needle arthroscopy biopsy specimens. Twenty four patients (11 RA, 8 spondyloarthropathy, 1 osteoarthritis, and 4 undifferentiated arthritis) were studied. FLS population doubling time was determined between passage 2 and passage 5. Differences in population doubling time between RA and non-RA FLS and between FLS from patients receiving MTX and those not receiving this drug were analysed. In addition, possible correlations between FLS population doubling time and patient age or disease duration were examined. RESULTS: In vitro monolayer FLS cultures from needle arthroscopy biopsy specimens showed linear growth characteristics. Cell growth rate was not correlated with type of disease. Cells from patients undergoing treatment with MTX showed a longer population doubling time than FLS from patients not receiving this drug (Mann-Whitney test, p

KW - Adult

KW - Age Factors

KW - Aged

KW - Antirheumatic Agents

KW - Arthritis

KW - Arthritis, Rheumatoid

KW - Biopsy, Needle

KW - Cell Division

KW - Cells, Cultured

KW - Female

KW - Fibroblasts

KW - Humans

KW - Male

KW - Methotrexate

KW - Middle Aged

KW - Synovial Membrane

KW - Time Factors

U2 - 10.1136/ard.62.6.568

DO - 10.1136/ard.62.6.568

M3 - Article

C2 - 12759297

VL - 62

SP - 568

EP - 571

JO - Annals of the Rheumatic Diseases

JF - Annals of the Rheumatic Diseases

SN - 0003-4967

IS - 6

ER -